Breast cancer risk in subset of OC users

Article

Oral contraceptives (OCs) are associated with a small increase in premenopausal breast cancer risk, especially in parous women who use them for 4 or more years before a first full-term pregnancy, according to a new meta-analysis.

Oral contraceptives (OCs) are associated with a small increase in premenopausal breast cancer risk, especially in parous women who use them for 4 or more years before a first full-term pregnancy, according to a new meta-analysis.

Chris Kahlenborn, MD, of Altoona Hospital in Altoona, Pa., and colleagues conducted a meta-analysis of 34 studies conducted since 1980. The researchers found that OCs were associated with a slightly increased risk of breast cancer in general (OR, 1.19). In studies that provided separate data for parous and nulliparous women who used OCs, they found OR of 1.29 and 1.24, respectively. The risk was highest in parous women who used OCs for at least 4 years before a first full-term pregnancy (OR, 1.52).

"Although oral contraceptives appear to be carcinogenic, the relative risk is small and the absolute risk (excess breast cancers due to OC exposure) is very small," stated the author of an accompanying editorial. "From the perspective of epidemiology and public health, we must continue to closely follow the epidemiology of OC use and health outcomes, given the widespread use of these agents and their high potential to impact women's health in both a beneficial and deleterious manner. The current study highlights the need for a close evaluation of OC use before first full-term pregnancy..."

Recent Videos
The significance of the Supreme Court upholding mifepristone access | Image Credit: unchealth.org
One year out: Fezolinetant displays patient satisfaction for managing hot flashes | Image Credit: sutterhealth.org
Addressing maternal health inequities: Insights from CDC's Wanda Barfield | Image Credit: cdc.gov
Addressing racial and ethnic disparities in brachial plexus birth Injury | Image Credit: shrinerschildrens.org
Innovations in prenatal care: Insights from ACOG 2024 | Image Credit:  uofmhealth.org.
Unlocking therapeutic strategies for menopausal cognitive decline | Image Credit: uclahealth.org.
Navigating menopause care: Expert insights from ACOG 2024 | Image Credit: mayo.edu.
raanan meyer, md
© 2024 MJH Life Sciences

All rights reserved.